Torsemide metabolism by CYP2C9 variants and other human CYP2C subfamily enzymes

被引:45
作者
Miners, JO [1 ]
Coulter, S
Birkett, DJ
Goldstein, JA
机构
[1] Flinders Med Ctr, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia
[2] Flinders Univ S Australia, Sch Med, Adelaide, SA 5001, Australia
[3] Natl Inst Environm Hlth Sci, Res Triangle Pk, NC USA
来源
PHARMACOGENETICS | 2000年 / 10卷 / 03期
关键词
torsemide; cytochrome P450; CYP2C9; sulphaphenazole inhibition; polymorphism;
D O I
10.1097/00008571-200004000-00008
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:267 / 270
页数:4
相关论文
共 19 条
[1]   Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications [J].
Aithal, GP ;
Day, CP ;
Kesteven, PJL ;
Daly, AK .
LANCET, 1999, 353 (9154) :717-719
[2]   Allelic and functional variability of cytochrome P4502C9 [J].
Bhasker, CR ;
Miners, JO ;
Coulter, S ;
Birkett, DJ .
PHARMACOGENETICS, 1997, 7 (01) :51-58
[3]  
HOLFORD NHG, 1985, CLIN EXPT PHARM S, V9, P95
[4]  
Ibeanu GC, 1999, J PHARMACOL EXP THER, V290, P635
[5]   Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole hydroxylase activity [J].
Ibeanu, GC ;
Ghanayem, BI ;
Linko, P ;
Li, LP ;
Pedersen, LG ;
Goldstein, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12496-12501
[6]   Pharmacokinetics of chlorpheniramine, phenytoin, glipizide and nifedipine in an individual homozygous for the CYP2C9*3 allele [J].
Kidd, RS ;
Straughn, AB ;
Meyer, MC ;
Blaisdell, J ;
Goldstein, JA ;
Dalton, JT .
PHARMACOGENETICS, 1999, 9 (01) :71-80
[7]   NORMAL METABOLISM OF DEBRISOQUINE AND THEOPHYLLINE IN A SLOW TOLBUTAMIDE METABOLIZER [J].
MINERS, JO ;
WING, LMH ;
BIRKETT, DJ .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1985, 15 (03) :348-349
[8]  
MINERS JO, 1995, J PHARMACOL EXP THER, V272, P1076
[9]   Cytochrome P4502C9: an enzyme of major importance in human drug metabolism [J].
Miners, JO ;
Birkett, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 45 (06) :525-538
[10]   TOLBUTAMIDE HYDROXYLATION BY HUMAN-LIVER MICROSOMES - KINETIC CHARACTERIZATION AND RELATIONSHIP TO OTHER CYTOCHROME-P-450 DEPENDENT XENOBIOTIC OXIDATIONS [J].
MINERS, JO ;
SMITH, KJ ;
ROBSON, RA ;
MCMANUS, ME ;
VERONESE, ME ;
BIRKETT, DJ .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (06) :1137-1144